Cystic fibrosis drugs given green light for sale in Canada, one step closer to patient access

Health Canada approved the marketing of the drug called Trikafta across the country on Friday. Medical experts feel cystic fibrosis patients could have access to this life-altering drug by the end of 2021.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting